文献速递膀胱癌与上尿路尿路上皮癌

老年肌层浸润性膀胱癌患者的根治性治疗:一项系统综述

Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review.
PubMed 文献 · Eur Urol · 2017-05-03

该系统综述检索Medline、PubMed和Embase数据库,纳入42篇年龄分层明确的文章,评估年龄>70岁非转移性肌层浸润性膀胱癌患者根治性治疗后的总生存、癌症特异性生存和并发症,并与年轻患者比较。结果显示总生存和癌症特异性生存随年龄显著恶化,围手术期死亡率随年龄显著增加,而并发症在年轻与老年患者间似乎相当。作者认为亟需评估老年综合评估的前瞻性研究以优化老年患者管理。

要点

  • 年龄>70岁非转移性肌层浸润性膀胱癌患者根治性治疗后总生存和癌症特异性生存随年龄显著恶化。
  • 根治性膀胱切除和放疗方案后围手术期死亡率随年龄显著增加,但并发症在年轻与老年患者间似乎相当。
  • 年龄对晚期并发症的影响较不明确,亟需评估老年综合评估的前瞻性研究。

核心结论

  • 尽管部分老年肌层浸润性膀胱癌患者可从根治性治疗中获益,但观察到的总生存、癌症特异性生存和围手术期死亡率随年龄恶化。
  • 年龄对晚期并发症的影响较不明确。
  • 亟需评估老年综合评估的前瞻性研究以优化老年肌层浸润性膀胱癌患者的管理。

研究设计与样本

  • 系统综述,检索Medline、PubMed和Embase数据库。
  • 纳入标准为涉及三个研究问题之一、患者数>100例且年龄分层明确的文章。
  • 共检索到42篇文章进行综述。

主要发现

  • 根治性膀胱切除和放疗方案后,总生存和癌症特异性生存均随年龄显著恶化。
  • 围手术期死亡率随年龄显著增加,而年轻与老年患者间并发症似乎相当。
  • 年龄对晚期并发症的影响较不明确。
  • 没有文章直接涉及老年综合评估的使用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 没有文章直接涉及老年综合评估的使用。
  • 亟需评估老年综合评估的前瞻性研究以优化老年肌层浸润性膀胱癌患者的管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The incidence of muscle invasive bladder cancer (MIBC) increases with age. With increased life expectancy the number of elderly MIBC patients is expected to increase. Existing guidelines on management of MIBC do not preclude curative treatments for elderly patients. However, it is necessary to assess the risks and benefits of a treatment to avoid overtreatment that results in decreased health-related quality of life without prolonging survival. OBJECTIVE: To report on overall survival (OS), cancer specific survival (CSS), and morbidity after curative treatment in elderly patients, defined as age >70 yr, with nonmetastatic MIBC and to compare this with the outcome of younger MIBC patients. EVIDENCE ACQUISITION: A systematic review was performed using Medline, PubMed, and Embase databases. Articles were included if they addressed one of the three research questions: Only articles including >100 patients and with a clear age-stratification were included. EVIDENCE SYNTHESIS: Forty-two articles were retrieved for review. No article directly addressed the use of geriatric assessment. OS and CSS worsen significantly with age both after radical cystectomy and radiotherapy regimens. While POM significantly increases with age, morbidity seems comparable between younger and older patients. CONCLUSIONS: Although a proportion of elderly patients with MIBC will benefit from curative treatment, we observed worse OS, CSS, and POM with age. The impact of age on late morbidity is less clear. Prospective studies evaluating geriatric assessments are critically needed to optimize MIBC management in the elderly. PATIENT SUMMARY: We performed a systematic review to evaluate the outcome and complication rate in elderly patients with muscle invasive bladder cancer. We observed that overall survival and cancer specific survival significantly decrease and perioperative mortality significantly increases with age. The impact of age on late morbidity is less clear. There is a need for geriatric assessments to select those patients that will benefit from curative treatment.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Fonteyne V, Ost P, Bellmunt J, et al. Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review. Eur Urol. 2017. PMID: 28478043. doi:10.1016/j.eururo.2017.03.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。